FDA 483 - Xinyu Pharmaceutical Co., Ltd. - March 11, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Xinyu Pharmaceutical Co., Ltd. in Suzhou, China, was inspected from March 11-15, 2019, and received a Form FDA 483 with four observations. The inspection revealed significant deficiencies in the firm's quality system, including inadequate change control for API quality, insufficient documentation practices for stability data, and a deficient system for maintaining and calibrating critical equipment. Additionally, the validation of GMP-related computerized systems was found to be inadequate.
ID · 0e6760db-5d5a-4439-85e6-9adc6f471c6a